EquiReason

EquiReason research coverage

Cytosorbents Corp CTSO

Healthcare · Medical Instruments & Supplies

16quarters analysed
12SEC filings read

Segments it reports

The business segments Cytosorbents Corp reports in its own SEC filings.

  • Single Reportable Segment

Where its revenue is reported

The geographies Cytosorbents Corp reports revenue for. How much comes from each is in the product.

  • All Other Countries
  • Germany
  • United States

What we read

The sources behind this company, and how many records of each we hold.

  • Financial statements22
  • Quarterly metric series12
  • SEC filings12
  • Insider transactions (Form 4)6
  • Institutional positions (13F)7
  • Earnings quality checks7
  • Estimate revisions10
  • Seasonal pattern6
  • Multi-period trajectory7
  • Inflection detection1
  • Fiscal calendar1
  • Index membership4

What we look for

Every company is run through the same checks. Both answers are reported — a signal we looked for and did not find is as much a fact as one we did.

  • Revenue series16
  • Margin series4
  • Cash flow series16
  • Earnings series16
  • Operating cash flow series16
  • Guidance changesnot found
  • Per-share seriesnot found

This page says how much of Cytosorbents Corp we have read. What any of it means — the direction, the dates, the evidence and what would overturn it — is inside the product.

Open CTSO in EquiReason

This page publishes coverage counts and reported breakdown names, but no financial figures, price data, rankings or investment conclusions. Sources are SEC filings, earnings calls and public institutional disclosures. How the research is made · All companies

Cytosorbents Corp (CTSO) — research coverage | EquiReason